CDKN2A and Miyoshi myopathy: In addition, treatment with phosphatase inhibitor cocktail I significantly decreased CDKN2A and phosphorylated CDKN2A levels in PI-resistant KAS-6/1 and U266 cells (Fig. 5F), suggesting that phosphorylation increases CDKN2A expression in PI-resistant MM cells.